Dow Jones
34.395,01 -194,76 (-0,56%) Nasdaq
11.482,45 +14,45 (+0,13%) Nikkei 225
27.777,90 -448,18 (-1,59%) EUR/USD
1,0530 +0,0001 (+0,01%) BTC-EUR
16.088,42 -274,16 (-1,68%) CMC Crypto 200
401,47 -4,68 (-1,15%)
PCAS SA (0NF7.L)
| Chiusura precedente | 18,30 |
| Aperto | 12,88 |
| Denaro | 0,00 x N/D |
| Lettera | 0,00 x N/D |
| Min-Max giorno | 12,88 - 12,88 |
| Intervallo di 52 settimane | 12,88 - 12,88 |
| Volume | |
| Media Volume | N/D |
| Capitalizzazione | N/D |
| Beta (5 anni mensile) | 0,51 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -2,95 |
| Prossima data utili | N/D |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
- GlobeNewswire
PCAS: appointment of a new Chairman
+ Ecully, November 28, 2022 APPOINTMENT OF A NEW CHAIRMAN At its meeting of November 28, 2022, the PCAS Board of Directors formally acknowledged the resignation of Mr. Philippe Clavel as Chief Executive Officer of PCAS. The Board of Directors thanked Mr. Philippe Clavel for his collaboration with PCAS Group. Consequently, the Board of Directors decided to appoint Mr. Jean-Louis Martin as Chief Executive Officer of PCAS. Mr. Jean-Louis Martin, currently Vice President Human Resources and Industri
- GlobeNewswire
PCAS: NET SALES AS OF SEPTEMBER 30, 2022
Ecully, November 3, 2022 NET SALES AS OF SEPTEMBER 30, 2022 PCAS (Euronext Paris: PCA), a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the publication of its consolidated net sales as of September 30, 2022. The PCAS Group has generated consolidated net sales of €156.1 million as of September 30, 2022, a 9.6% increase compared to the same period during the previous financial year (+7.1% at constant exchange rates). In millio
- GlobeNewswire
1st HALF 2022 EARNINGS REPORT
Ecully, September 8, 2022 1st HALF 2022 EARNINGS REPORT PCAS (Euronext Paris: PCA), a specialist in the development and production of complex molecules for life sciences and innovative technologies, announces the publication of its consolidated earnings for the first half of 2022. 30 June 2021 30 June 2022 in millions of euros Net sales 106.3 109.8 EBITDA (*) 8.0 -0.5 EBITDA margin 7.5% -0.5% Current operating income (*) -2.6 -15.3 Other operating income and expenses -0.4 -14.7 Operating income
